Midregional Proadrenomedullin (MRproADM) Serum Levels in Critically Ill Patients Are Associated with Short-Term and Overall Mortality during a Two-Year Follow-Up

Midregional Proadrenomedullin (MRproADM) Serum Levels in Critically Ill Patients Are Associated with Short-Term and Overall Mortality during a Two-Year Follow-Up

Adrenomedullin (ADM) is a peptide with pleiotropic effects in systemic inflammation. Its more stable precursor protein midregional proadrenomedullin (MRproADM) can be measured more reliably compared to ADM. Our objective was to investigate the potential role of MRproADM as a diagnostic and prognosti...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Lukas Buendgens, Eray Yagmur, Axel Ginsberg, Ralf Weiskirchen, Theresa Wirtz, Samira Abu Jhaisha, Albrecht Eisert, Tom Luedde, Christian Trautwein, Frank Tacke, Alexander Koch
Materialtyp: Artikel
Språk:English
Publicerad: Hindawi Limited 2020-01-01
Serie:Mediators of Inflammation
Länkar:http://dx.doi.org/10.1155/2020/7184803

Internet

http://dx.doi.org/10.1155/2020/7184803

Liknande verk